Sarkar et al. [32] also reported that a BRACHYURY knockdown via siRNA resulted in downregulation of expression of CD44, CD166, CD133, ALDH1, and NANOG in colon cancer, and they concluded that BRACHYURY participates in establishment of CSC characteristics by inducing NANOG expression. Here, CD44 is linked to malignant colon neoplasm.